Christopher U. Missling

President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer at Anavex Life Sciences Corp.

Christopher U. Missling

Christopher U. Missling

President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer at Anavex Life Sciences Corp.

Overview
Career Highlights

Immunogen Inc.
Curis Inc.
Anavex Life Sciences Corp.

RelSci Relationships

204

Number of Boards

1

Birthday

1966

Age

54

Relationships
RelSci Relationships are individuals Christopher U. Missling likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Anavex Life Sciences Corp.

Relationship likelihood: Strong

Former Chief Scientific Officer at Anavex Life Sciences Corp.

Relationship likelihood: Strong

Secretary, Treasurer & Chief Accounting Officer at Humanigen, Inc.

Relationship likelihood: Strong

Founder & Chief Executive Officer at Favus Institutional Research LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Anavex Life Sciences Corp.

Relationship likelihood: Strong

Former Attorney at Epping Hermann Fischer Patentanwaltsgesellschaft mbH

Relationship likelihood: Strong

Member, Board of Directors at Anavex Life Sciences Corp.

Relationship likelihood: Strong

Associate Professor, Pathology & Cell Biology at Columbia University Medical Center

Relationship likelihood: Strong

Vice President, Global Product Development-Neuroscience Team at Pharmaceutical Product Development LLC

Relationship likelihood: Strong

Head of Neuropsychology at CeNeS Pharmaceuticals Plc

Relationship likelihood: Strong

Paths to Christopher U. Missling
Potential Connections via
Relationship Science
You
Christopher U. Missling
President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer at Anavex Life Sciences Corp.
Education
Graduate

Ludwig-Maximilians-Universität München is a premier academic and research institutions.

MBA Unknown

The Kellogg School of Management (The Kellogg School or Kellogg) is the business school of Northwestern University in Evanston, Illinois, with additional campuses in downtown Chicago, Illinois and Miami, Florida. Kellogg offers full-time, part-time, and executive programs, and partners with schools in China, France/Singapore, India, Hong Kong, Israel, Germany, Canada, and Thailand.Founded in 1908 in downtown Chicago as a part-time evening program, the school was chartered to educate business leaders with "good moral character.

WHU - Otto Beisheim School of Management is an educational and research institute. The school offers bachelors, masters, and doctoral programs and research programs and courses focusing on business management, finance, accounting, entrepreneurship, leadership and human resource management, economics, and marketing. WHU - Otto Beisheim School of Management was founded in 1984 and is based in Vallendar, Germany.

Career History
President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer
2013 - Current

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Chief Financial Officer
Prior

ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.

Chief Financial Officer
Prior

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Transactions
Details Hidden

Anavex Life Sciences Corp. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Christopher U. Missling is affiliated with Anavex Life Sciences Corp., Immunogen Inc., Curis Inc., Brimberg & Co.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher U. Missling. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher U. Missling's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher U. Missling.